Robert D. Thompson
Vorstandsvorsitzender bei Lewis & Clark Pharmaceuticals, Inc.
Aktive Positionen von Robert D. Thompson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Lewis & Clark Pharmaceuticals, Inc.
 Lewis & Clark Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Lewis & Clark Pharmaceuticals, Inc. develops adenosine receptor-based compounds. The firm focuses on A2A and A2B antagonists, and A2A agonists. It offers chemical synthesis and analysis, non-clinical dose formulation and plasma concentration analysis, assay development, toxicology and non-clinical consulting. The company was founded by Robert D. Thompson, David K. Glover and Julien Dimastromatteo in 2011 and is headquartered in Charlottesville, VA. | Vorstandsvorsitzender | 01.01.2012 | - |
| Vorsitzender | 01.01.2011 | - | |
| Gründer | 01.01.2012 | - |
Karriereverlauf von Robert D. Thompson
Statistik
International
| Vereinigte Staaten | 2 |
Operativ
| Chief Executive Officer | 1 |
| Chairman | 1 |
| Founder | 1 |
Sektoral
| Retail Trade | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Lewis & Clark Pharmaceuticals, Inc.
Lewis & Clark Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Lewis & Clark Pharmaceuticals, Inc. develops adenosine receptor-based compounds. The firm focuses on A2A and A2B antagonists, and A2A agonists. It offers chemical synthesis and analysis, non-clinical dose formulation and plasma concentration analysis, assay development, toxicology and non-clinical consulting. The company was founded by Robert D. Thompson, David K. Glover and Julien Dimastromatteo in 2011 and is headquartered in Charlottesville, VA. | Retail Trade |
- Börse
- Insiders
- Robert D. Thompson
- Erfahrung
